Paritaprevir/ritonavir-ombitasvir and dasabuvir, the 3D regimen for the treatment of chronic hepatitis C virus infection: a concise review

Hussaini T

Hepatic Medicine: Evidence and Research 2016, 8:61-68

Published Date: 18 May 2016